Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis

To date, the impact of background glucocorticoids (GC) on the efficacy and safety of abatacept or adalimumab in patients with active rheumatoid arthritis (RA) is not clearly established. This post hoc analysis of (AMPLE) trial (NCT00929864) compared efficacy and safety outcomes over 2 years in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Degboé, Yannick, Schiff, Michael, Weinblatt, Michael, Fleischmann, Roy, Ahmad, Harris A., Constantin, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356046/
https://www.ncbi.nlm.nih.gov/pubmed/32604962
http://dx.doi.org/10.3390/jcm9062017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356046/
https://www.ncbi.nlm.nih.gov/pubmed/32604962
http://dx.doi.org/10.3390/jcm9062017

Ejemplares similares